Prescribing cannibinoid products

+Educate
EDUCATION

Prescribing cannibinoid products

Sanya Ram
Medical marijuana
Regulating medicinal cannabis is difficult and complex

The prescribing and use of cannabis-based medicines is strictly regulated in New Zealand. University of Auckland pharmacy law lecturer Sanya Ram explores the current legal requirements for prescribing and dispensing cannabinoid products

The therapeutic potential for medicinal cannabis has been topical and has pro­voked much debate globally. Regulating medicinal cannabis is difficul
References
  1. Zolotov Y, Vulfsons S, Zarhin D, et al. Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. Int J Drug Policy 2018;57(7):4–10.
  2. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 2015;313(24):2456–73.
  3. Misuse of Drugs Act,1975 (NZ).
  4. Misuse of Drugs Regulations,1977 (NZ).
  5. Ministry of Health. CBD products. Available from: www.health.govt.nz (Accessed May, 2018).
  6. Ministry of Health. Prescribing cannabis based products. Available from: www.health. govt.nz (Accessed May, 2018).
  7. Misuse of Drugs Regulations,1977 (NZ), regulation 29 (1A).
  8. Medicines Act, 1981 (NZ), s29.
  9. Medsafe. Sativex oromucosal spray. Available from: www.medsafe.govt.nz (Accessed May 2018).